OPGEN

opgen-logo

Headquartered in Rockville, Maryland, OpGen (NASDAQ:OPGN) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. OpGen, along with its subsidiaries, Curetis and Ares Genetics, develop and commercialize molecular microbiology solutions to help guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes. Our innovative approaches to infectious disease diagno... stics consist of highly multiplexed syndromic molecular panels, and next-generation sequencing combined with smart bioinformatics and artificial intelligence to address the global threat of antimicrobial resistance (AMR). By integrating these capabilities, we provide unique rapid molecular diagnostic products and services that help to dramatically transform patient care by using precision medicine to guide antibiotic therapy selection and optimize the treatment of life-threatening drug-resistant infections, improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms (MDROs). OpGen Community (Linkedin Group) provides an accessible environment to share information, exchange questions and best practices using OpGenโ€™s technologies in a variety of applications.

#SimilarOrganizations #People #Financial #Event #Website #More

OPGEN

Social Links:

Industry:
Biotechnology Genetics Health Care

Founded:
2002-01-01

Address:
Rockville, Maryland, United States

Country:
United States

Website Url:
http://www.opgen.com

Total Employee:
101+

Status:
Active

Contact:
+3018699683

Total Funding:
158.73 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

color-logo

Color

Color is a complete platform for healthcare delivery.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.


Current Advisors List

prabhavathi-fernandes_image

Prabhavathi Fernandes Director @ OpGen
Board_member

mario-crovetto_image

Mario Crovetto Director @ OpGen
Board_member

r-don-elsey_image

R Don Elsey Director @ OpGen
Board_member

william-rhodes_image

William Rhodes Chairman Of The Board @ OpGen
Board_member
2019-04-01

Current Employees Featured

oliver-schacht_image

Oliver Schacht
Oliver Schacht President and CEO @ OpGen
President and CEO
2020-04-01

johannes-bacher_image

Johannes Bacher
Johannes Bacher Chief Operating Officer @ OpGen
Chief Operating Officer

oliver-schacht_image

Oliver Schacht
Oliver Schacht CEO @ OpGen
CEO
2021-01-01

albert-weber_image

Albert Weber
Albert Weber Chief Financial Officer @ OpGen
Chief Financial Officer
2021-01-01

faranak-atrzadeh_image

Faranak Atrzadeh
Faranak Atrzadeh Chief Marketing and Scientific Affairs Officer @ OpGen
Chief Marketing and Scientific Affairs Officer

albert-risdorfer_image

Albert Risdorfer
Albert Risdorfer Sr Director Human Resources @ OpGen
Sr Director Human Resources
2015-12-01

Founder


not_available_image

David Schwartz

Stock Details


Company's stock symbol is NASDAQ:OPGN

Acquisitions List

Date Company Article Price
2015-07-14 AdvanDx AdvanDx acquired by OpGen N/A

Investors List

merck-global-health-innovation-fund_image

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund investment in Post-IPO Equity - OpGen

sabby-management_image

Sabby Management

Sabby Management investment in Post-IPO Equity - OpGen

merck-global-health-innovation-fund_image

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund investment in Post-IPO Equity - OpGen

180-degree-capital_image

180 Degree Capital

180 Degree Capital investment in Series C - OpGen

chl-medical-partners_image

CHL Medical Partners

CHL Medical Partners investment in Series C - OpGen

jven-capital_image

jVen Capital

jVen Capital investment in Series C - OpGen

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series C - OpGen

highland-capital-partners_image

Highland Capital Partners

Highland Capital Partners investment in Series C - OpGen

cross-creek-capital_image

Cross Creek

Cross Creek investment in Series C - OpGen

mason-wellsbiomediacl-fund_image

Mason Wells

Mason Wells investment in Series B - OpGen

Investments List

Date Company Article Money raised
2012-03-22 BioRelix OpGen investment in Venture Round - BioRelix 2.56 M USD

Key Employee Changes

Date New article
2021-11-04 OpGen Appoints Albert Weber as Chief Financial Officer

Official Site Inspections

http://www.opgen.com Semrush global rank: 4.52 M Semrush visits lastest month: 2.35 K

  • Host name: 49.122.212.35.bc.googleusercontent.com
  • IP address: 35.212.122.49
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "OpGen"

About OpGen - diagnostic solutions

Headquartered in Rockville, Maryland, OpGen is a precision medicine company harnessing the power of molecular diagnostics to help combat infectious โ€ฆSee details»

OpGen (OPGN) Company Profile & Description - Stock Analysis

6 days ago OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States โ€ฆSee details»

OpGen - Crunchbase Company Profile & Funding

OpGen is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious diseases. OpGen, along with its subsidiaries, Curetis โ€ฆSee details»

OpGen, Inc. | LinkedIn

OpGen, Inc. | 3,660 followers on LinkedIn. Mission We harness the power of molecular microbiology to develop diagnostic solutions that will optimize the treatment of life-threatening, โ€ฆSee details»

OPGN - OpGen, Inc. | Company Profile | OTC Markets

Mar 24, 2025 OpGen, Inc. 23219 Stringtown Road. Suite 300. Clarksburg, MD 20871 . www.opgen.com (240) 813-1260. [email protected]. Business Description. โ€ฆSee details»

OpGen, Inc. (OPGN) Company Profile & Facts - Yahoo Finance

See the company profile for OpGen, Inc. (OPGN) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives โ€ฆSee details»

OpGen - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โ€ฆSee details»

OpGen - The Org

OpGen is uniquely positioned to address the rising antibiotic resistance crisis and is harnessing the power of informatics and genomic analysis to provide complete solutions to protect โ€ฆSee details»

OpGen - businessabc

Feb 25, 2025 OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage โ€ฆSee details»

OpGen Company Profile - Office Locations, Competitors, Revenue โ€ฆ

Oct 29, 2024 OpGen has 4 employees across 4 locations and $3.42 m in annual revenue in FY 2023. See insights on OpGen including office locations, competitors, revenue, financials, โ€ฆSee details»

Board of Directors - OpGen

Chief Executive Officer and Chairman. Full Bio. Christian-Laurent BonteSee details»

OpGen Provides Update on Business Operations and Strategic โ€ฆ

Apr 29, 2024 About OpGen, Inc. OpGen, Inc. (Rockville, Md., U.S.A.) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat โ€ฆSee details»

OpGen - Devex

OpGen is uniquely positioned to address the rising antibiotic resistance crisis and is harnessing the power of informatics and genomic analysis to provide complete solutions to protect โ€ฆSee details»

Investors - OpGen, Inc.

Overview. OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease.We are developing molecular โ€ฆSee details»

OpGen, Inc. (OPGN): history, ownership, mission, how it works

[relinking] Home History Owners Mission How It Works How It Makes Money OpGen, Inc. (OPGN) Information A Brief History of OpGen, Inc. (OPGN) Company Overview OpGen, Inc. is a โ€ฆSee details»

OpGen - Contacts, Employees, Board Members, Advisors & Alumni โ€ฆ

Organization. OpGen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contacts 28. About. OpGen has 6 current employee โ€ฆSee details»

OpGen Subsidiary Ares Genetics Announces its Move to New โ€ฆ

ROCKVILLE, Md., March 01, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, โ€œOpGenโ€), a precision medicine company harnessing the power of molecular diagnostics and โ€ฆSee details»

OpGen - bioforward.org

Annual Member Meeting. April 29, 2025-April 29, 2025 |See details»

OpGen Provides Business and Pipeline Update and Announces โ€ฆ

This press release includes statements regarding OpGenโ€™s third quarter 2020 results, the companyโ€™s strategic portfolio and product pipeline priorities, the ongoing integration of OpGen โ€ฆSee details»

OpGen - Edison Group

Feb 28, 2025 OpGen is primarily a lab diagnostic manufacturer focused on identifying and treating bacterial infections. It has the technology to detect pathogens and predict resistance. Through the dual platform offering of the AMR Gene Panel and Unyvero, it can provide diagnostic results in hours instead of days.See details»

linkstock.net © 2022. All rights reserved